[Performance based regulation: a strategy to increase breastfeeding rates].
Fernanda Cobo-Armijo1, Sofía Charvel1, Mauricio Hernández-Ávila2
1Programa de Derecho y Salud Pública, Departamento Académico de Derecho, Instituto Tecnológico Autónomo de México. Ciudad de México, México.
Salud Publica De Mexico
|September 14, 2017
Summary
Performance-Based Regulation (PBR) offers an innovative strategy to address declining breastfeeding rates in Mexico. This approach holds the breastmilk substitute industry financially accountable for hindering breastfeeding, promoting public health.
Area of Science:
- Public Health
- Health Policy
- Regulatory Science
Background:
- Declining breastfeeding rates in Mexico present a significant public health challenge.
- Existing strategies have not adequately reversed this trend, necessitating innovative solutions.
Purpose of the Study:
- To introduce and evaluate Performance-Based Regulation (PBR) as a novel regulatory strategy to improve breastfeeding rates in Mexico.
- To assess the feasibility of applying PBR to the breastmilk substitute industry.
Main Methods:
- The study proposes applying PBR, a regulatory approach that links compliance to financial penalties.
- It analyzes the structure of the breastmilk substitute market in Mexico to determine industry accountability.
- Key regulatory parameters, including target population and standard evaluation, are examined for feasibility.
Main Results:
- PBR is deemed feasible due to the oligopolistic nature of the breastmilk substitute market, allowing for clear identification of industry contributions.
- The defined target population and clear regulatory standards facilitate objective evaluation.
- Objective parameters for sanctions ensure effective enforcement.
Conclusions:
- Performance-Based Regulation is a viable strategy to improve breastfeeding rates in Mexico.
- Recommendations include modifying public policy, industry concertation, creating effective sanctions, strengthening enforcement, and aligning with the International Code of Marketing of Breast-milk Substitutes.
More Related Videos
Related Concept Videos
01:25Drug Regulation
3.2K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
3.2K
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
30
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
30
01:52Regression Toward the Mean
7.2K
Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
7.2K
01:03Drug Control Governance: Regulatory Bodies and Their Impact
612
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
612
01:23Methods of Documentation V: CBE
1.5K
Charting by Exception, or CBE, is a method of documentation used in healthcare, particularly in nursing, that focuses on documenting only significant or abnormal findings rather than recording every detail. This approach aims to streamline the documentation process, improve efficiency, and ensure that healthcare providers can quickly identify deviations from normalcy in patient assessments.
In CBE, healthcare professionals establish predefined standards of practice that define what constitutes...
In CBE, healthcare professionals establish predefined standards of practice that define what constitutes...
1.5K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
500
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
500